FOXP3 and tuberculosis: (2) Exogenous IL-35 treatment could induce the elevation in the counts of IL-35-producing B cells and promote their infiltration into the lung tissue, further downregulating the infiltration of anti-tuberculosis effector cell Th1/Th17 and upregulating the infiltration of Foxp3+ regulatory T cells into the lung tissue.